Evidence map›Paper›PMID 23308116›Full record

SynthesisPloS one2013

Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review.

Brett D Thombs, Michelle Roseman, James C Coyne, Peter de Jonge, Vanessa C Delisle, Erin Arthurs, Brooke Levis, Roy C Ziegelstein

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Depression Screening and Health Outcomes in Children and Adolescents: A Systematic Review.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2017
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Significance of psychosocial factors in cardiology: update 2018 : Position paper of the German Cardiac Society.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Brett D ThombsDepartment of Psychiatry, McGill University, Montréal, Quebéc, Canada. brett.thombs@mcgill.ca
Michelle Roseman
James C Coyne
Peter de Jonge
Vanessa C Delisle
Erin Arthurs
Brooke Levis
Roy C Ziegelstein
McGill University · CAJewish General Hospital · CAJohns Hopkins Medicine · USUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

Canadian Institutes of Health Research KRS 111754
6 · The paper itself

Abstract

objectivesTo systematically review evidence on depression screening in coronary heart disease (CHD) by assessing the (1) accuracy of screening tools; (2) effectiveness of treatment; and (3) effect of screening on depression outcomes.

backgroundA 2008 American Heart Association (AHA) Science Advisory recommended routine depression screening in CHD.

methodsCINAHL, Cochrane, EMBASE, ISI, MEDLINE, PsycINFO and SCOPUS databases searched through December 2, 2011; manual journal searches; reference lists; citation tracking; trial registries. Included articles (1) compared a depression screening instrument to a depression diagnosis; (2) compared depression treatment to placebo or usual care in a randomized controlled trial (RCT); or (3) assessed the effect of screening on depression outcomes in a RCT.

resultsThere were few examples of screening tools with good sensitivity and specificity using a priori-defined cutoffs in more than one patient sample among 15 screening accuracy studies. Depression treatment with antidepressants or psychotherapy generated modest symptom reductions among post-myocardial infarction (post-MI) and stable CHD patients (N = 6; effect size = 0.20-0.38), but antidepressants did not improve symptoms more than placebo in 2 heart failure (HF) trials. Depression treatment did not improve cardiac outcomes. No RCTs investigated the effects of screening on depression outcomes.

conclusionsThere is evidence that treatment of depression results in modest improvement in depressive symptoms in post-MI and stable CHD patients, although not in HF patients. There is still no evidence that routine screening for depression improves depression or cardiac outcomes. The AHA Science Advisory on depression screening should be revised to reflect this lack of evidence.

Indexed as

American Heart AssociationAntidepressive AgentsCoronary DiseaseDepressive DisorderHumansPrognosisTreatment OutcomeUnited StatesAntidepressive Agents

Identifiers

PMID23308116
PMCPMC3538724
OpenAlexW2028539407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.